This is a remarkable project that has come together through extraordinary circumstances. I can only hope that our ultimate outcome will be as extraordinary and that we can help children around the world have a healthier start in life. Currently, more than a million children in developing countries die each year from measles because they cannot be safely and effectively immunized. Needles are expensive and difficult to handle in challenging environments. In extreme cases, caregivers must choose between inoculating a child and potentially transmitting blood-borne diseases by reusing a needle.
Needles are expensive and difficult to handle in challenging environments.
In extreme cases, caregivers must choose between inoculating a child and potentially transmitting blood-borne diseases by reusing a needle. CADB s unique technology includes a protective barrier that prevents the transfer of pathogens between patients. Felton Medical has filed for a family of national and international patents on the technology and units, and will file for FDA approval within the next three months. Felton Medical has filed for a family of national and international patents on the technology and units, and will file for FDA approval within the next three months. The World Health Organization has confirmed the need for this type of device.